MONTREAL, May 13, 2025 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore” or “the Corporation”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for the three-month and nine-month periods ended March 31, 2025. All amounts in this press release are in Canadian dollars, unless otherwise stated. Key Financial Highlights Q3-2025 Total revenues of $30,446,165 compared to $33,867,747 last year, representing a 10% decrease;Adjusted gross margin(1) on revenues from cust ...

HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended March 31, 2025. Net Loss of $(30.4) million, or $(0.57) per diluted shareAdjusted Net Loss of $(50.3) million, or $(0.94) per diluted shareAdjusted EBITDA of $10.1 millionRepurchased $51 million of common stock, or 3.6 million shares, during the first quarterWyoming refinery returned to full crude operations one month ahead of schedule ...

Core Insights - Exosens reported strong revenue growth in Q1 2025, achieving €104.9 million, a 21.1% increase compared to Q1 2024, driven by robust demand in Defense markets [7][8][10] - The company is on track to meet its 2025 guidance, expecting high-teens revenue growth and low twenties adjusted EBITDA growth [3][23] Financial Performance - Total revenue for Q1 2025 was €104.9 million, up €18.3 million from Q1 2024, with a like-for-like growth of 18.0% [6][7] - Amplification revenue reached €81.7 million, reflecting a significant growth of 29.1% year-over-year, primarily due to increased demand for night vision applications [9][10] - Detection & Imaging revenue slightly declined to €24.0 million, down 1.0% compared to Q1 2024, impacted by temporary challenges in the Telops segment [11][12] Margin Analysis - Adjusted gross margin increased by 28.1% to €52.6 million in Q1 2025, with a margin rate of 50.1%, up 270 basis points from the previous year [8][17] - The Amplification segment's adjusted gross margin grew by 39.5% to €40.8 million, with a margin rate of 49.9% [18] - Detection & Imaging segment's adjusted gross margin remained stable at €11.8 million, with a margin rate improvement to 49.3% [19] Market Dynamics - The demand for Exosens' products is bolstered by increasing geopolitical tensions and sustained investments from NATO and Tier-1 allies [4][10] - The company anticipates continued growth in its Defense-related activities, with expectations for the Detection & Imaging segment to recover and accelerate throughout 2025 [12][23] Strategic Developments - Exosens completed the acquisition of Noxant, enhancing its capabilities in high-performance cooled infrared imaging, particularly for Defense and Surveillance applications [13][14] - The integration of Noxant is underway, expected to be finalized by the end of June 2025 [14] Governance and Shareholder Updates - Bpifrance Investissement is proposed for appointment to the Board of Directors, following an increase in its stake to 7.2% of Exosens' share capital [20][21] - The company maintains a leverage ratio target of around 2x while pursuing its growth strategy [24]

NCS Multistage Holdings, Inc. (NASDAQ:NCSM) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ET Company Participants Mike Morrison - Chief Financial Officer Ryan Hummer - Chief Executive Officer Conference Call Participants Dave Storms - Stonegate John Daniel - Daniel Energy Partners Operator Good day and thank you for standing by. Welcome to the Q4 and Full Year 2024 NCS Multistage Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, t ...